Incannex Healthcare (IXHL) EPS (Basic) (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly EPS (Basic) of -$0.31 for Q1 2026, up 94.81% year-on-year from -$0.16 in Q1 2025, and up 43.83% on a QoQ basis from -$0.56 in Q4 2025.
Incannex Healthcare (IXHL) EPS (Basic) (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported EPS (Basic) for 5 consecutive years, with -$0.31 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 94.81% year-over-year to -$0.31 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.92 (up 88.18% YoY) and the FY2025 annual result came in at -$40.82, down 19.16% from the prior year.
- EPS (Basic) rose to -$0.31 in Q1 2026 per IXHL's latest filing, from -$0.56 in the prior quarter.
- Over the last five years, EPS (Basic) for IXHL reached as high as -$0.31 in Q1 2026 and fell as low as -$138.05 in Q4 2022.
- A 5-year average of -$17.28 and a median of -$8.68 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 571.67% — and 2026, when it soared 94.81%.
- Year by year, EPS (Basic) stood at -$138.05 in 2022, then soared by 92.82% to -$9.91 in 2023, then fell by 1.28% to -$10.03 in 2024, then jumped by 94.42% to -$0.56 in 2025, then soared by 43.83% to -$0.31 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.31, -$0.56, and -$0.62 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.31 |
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -27.52 |
| Mar 31, 2025 | -6.06 |
| Dec 31, 2024 | -10.03 |
| Sep 30, 2024 | -9.22 |
| Jun 30, 2024 | -11.94 |
| Mar 31, 2024 | -11.40 |
| Dec 31, 2023 | -9.91 |
| Sep 30, 2023 | -1.37 |
| Jun 30, 2023 | -8.14 |
| Mar 31, 2023 | -6.75 |
| Dec 31, 2022 | -138.05 |